Inpixon

NASDAQ:INPXUnited States

NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

Nov 14, 2023

Show headlines and story abstract

• -- Earnings Flash (INPX) INPIXON Posts Q3 Revenue $2M, from 4:14PM ET on Tuesday Nov 14, 2023 by MT Newswires

  4:14PM ET on Tuesday Nov 14, 2023 by MT Newswires
  Companies Mentioned: INPX
  04:14 PM EST, 11/14/2023 (MT Newswires) -- ...

• Inpixon Reports Third Quarter 2023 Financial Results and Provides Business Update, from 4:05PM ET on Tuesday Nov 14, 2023 by PR Newswire

  4:05PM ET on Tuesday Nov 14, 2023 by PR Newswire
  Companies Mentioned: INPX

  Entered into a Definitive Merger Agreement with XTI Aircraft;Transaction Expected to be Completed during the Fourth Quarter of 2023

  Entered into a Definitive Agreement to Spin-off and MergeInpixon's SAVES UK Business with Damon Motors Inc.

• Inpixon Reports Third Quarter 2023 Financial Results and Provides Business Update, from 4:05PM ET on Tuesday Nov 14, 2023 by Dow Jones

  4:05PM ET on Tuesday Nov 14, 2023 by Dow Jones
  Companies Mentioned: INPX
  Net proceeds from issuance of warrants 1,409 -- Repayment of CXApp acquisition liability (197) (1,957) Distribution to shareholders related to spin-off of CXApp (10,003) -- Common shares issued for net proceeds from warrants 2,341 -- ----------- ----------- Net Cash Provided By Financing Activities $ 20,185 $ 902 Effect of Foreign Exchange Rate on Changes on Cash (12) (34) Net (Decrease) Increase in Cash and Cash Equivalents (6,746) 10,673 Cash and Cash Equivalents - Beginning of year 20,235 52,480 ----------- ----------- Cash and Cash Equivalents - End of year $ 13,489 $ 63,153 =========== =========== Reconciliation of Non-GAAP Financial Measures: For the Three Months Ended For the Nine Months Ended September 30, September 30, ------------------------------ (In thousands) 2023 2022 2023 2022 ------------------------------ -------------- ---------------- -------------- ------------ Net loss attributable to common stockholders $ (10,384) $ (22,631) $ (34,224) $ (64,850) Loss from discontinued operations, net of tax - 7,121 4,856 22,786 Interest expense, net 818 234 4,300 65 Income tax provision 3 - 2,488 22 Depreciation and amortization 433 705 1,277 2,123 -------------- ---------------- -------------- ------------ EBITDA (9,130) (14,571) (21,303) (39,854) Adjusted for: Non-recurring one-time charges: Unrealized (gain)/loss on equity securities (5,791) 5,854 (5,733) 7,110 Realized loss on equity securities 6,692 151 6,692 151 Unrealized gain on note - 153 - 325 Acquisition transaction/financing costs 1,656 2 2,343 254 Professional service fees - - - 8 Impairment of goodwill - - - 2,030 Transaction costs 1,527 - 2,970 - Accretion of series 7 preferred stock - - - 4,555 Accretion of series 8 preferred stock - 6,305 - 13,089 Deemed dividend for the modification related to Series 8 preferred stock - - - 2,627 Deemed contribution for the modification related to warrants issued in connection with the Series 8 Preferred Stock - - - (1,469) Amortization premium - modification to Series 8 preferred stock - (1,265) - (2,626) Distribution of equity method investment shares to employees as compensation - - 666 - Gain on equity securities - - (1,142) - Loss on exchange of debt for equity 124 - 124 - Unrealized foreign exchange losses 354 1,019 209 1,143 Bad debts expense/provision - - 24 - Reserve for inventory obsolescence (8) - 8 - Stock-based compensation -- compensation and related benefits 227 688 797 2,962 Severance costs 244 239 371 301 Adjusted EBITDA $ (4,105) $ (1,425) $ (13,974) $ (9,394) ============== ================ ============== ============ For the Three Months Ended For the Nine Months Ended September 30, September 30, ------------------------------ (In thousands, except share data) 2023 2022 2023 2022 ------------------------------ -------------- ---------------- -------------- ------------ Net loss attributable to common stockholders $ (10,384) $ (22,631) $ (34,224) $ (64,850) Adjustments: Non-recurring one-time charges: Loss from discontinued operations, net of tax - 7,121 4,856 22,786 Unrealized (gain)/loss on equity securities (5,791) 5,854 (5,733) 7,110 Realized loss on equity securities 6,692 151 6,692 151 Unrealized gain on note - 153 - 325 Acquisition transaction/financing costs 1,656 2 2,343 254 Professional service fees - - - 8 Impairment of goodwill - - - 2,030 Transaction costs 1,527 - 2,970 - Accretion of series 7 preferred stock - - - 4,555 Accretion of series 8 preferred stock - 6,305 - 13,089 Deemed dividend for the modification Series 8 preferred stock - - - 2,627 Deemed contribution for the modification related to warrants issued in connection with the Series 8 Preferred Stock - - - (1,469) Amortization premium - modification to Series 8 preferred stock - (1,265) - (2,626) Distribution of equity method investment shares to employees as compensation - - 666 - Gain on equity securities - - (1,142) - Loss on exchange of debt for equity 124 - 124 - Unrealized foreign exchange losses 354 1,019 209 1,143 Bad debts expense/provision - - 24 - Reserve for inventory obsolescence (8) - 8 - Stock-based compensation - compensation and related benefits 227 688 797 2,962 Severance costs 244 239 371 301 Amortization of intangibles 221 511 671 1,640 Proforma non-GAAP net loss $ (5,138) $ (1,853) $ (21,368) $ (9,964) ============== ================ ============== ============ Proforma non-GAAP net loss per common share - basic and diluted $ (0.08) $ (0.84) $ (0.60) $ (4.78) ============== ================ ============== ============ Weighted average basic and diluted common shares outstanding 65,840,189 2,216,544 35,845,916 2,086,633 ============== ================ ============== ============
  

• *DJ Inpixon 3Q Loss/Shr 16c >INPX, from 4:05PM ET on Tuesday Nov 14, 2023 by Dow Jones

  4:05PM ET on Tuesday Nov 14, 2023 by Dow Jones
  Companies Mentioned: INPX
  Net proceeds from issuance of warrants 1,409 -- Repayment of CXApp acquisition liability (197) (1,957) Distribution to shareholders related to spin-off of CXApp (10,003) -- Common shares issued for net proceeds from warrants 2,341 -- ----------- ----------- Net Cash Provided By Financing Activities $ 20,185 $ 902 Effect of Foreign Exchange Rate on Changes on Cash (12) (34) Net (Decrease) Increase in Cash and Cash Equivalents (6,746) 10,673 Cash and Cash Equivalents - Beginning of year 20,235 52,480 ----------- ----------- Cash and Cash Equivalents - End of year $ 13,489 $ 63,153 =========== =========== Reconciliation of Non-GAAP Financial Measures: For the Three Months Ended For the Nine Months Ended September 30, September 30, ------------------------------ (In thousands) 2023 2022 2023 2022 ------------------------------ -------------- ---------------- -------------- ------------ Net loss attributable to common stockholders $ (10,384) $ (22,631) $ (34,224) $ (64,850) Loss from discontinued operations, net of tax - 7,121 4,856 22,786 Interest expense, net 818 234 4,300 65 Income tax provision 3 - 2,488 22 Depreciation and amortization 433 705 1,277 2,123 -------------- ---------------- -------------- ------------ EBITDA (9,130) (14,571) (21,303) (39,854) Adjusted for: Non-recurring one-time charges: Unrealized (gain)/loss on equity securities (5,791) 5,854 (5,733) 7,110 Realized loss on equity securities 6,692 151 6,692 151 Unrealized gain on note - 153 - 325 Acquisition transaction/financing costs 1,656 2 2,343 254 Professional service fees - - - 8 Impairment of goodwill - - - 2,030 Transaction costs 1,527 - 2,970 - Accretion of series 7 preferred stock - - - 4,555 Accretion of series 8 preferred stock - 6,305 - 13,089 Deemed dividend for the modification related to Series 8 preferred stock - - - 2,627 Deemed contribution for the modification related to warrants issued in connection with the Series 8 Preferred Stock - - - (1,469) Amortization premium - modification to Series 8 preferred stock - (1,265) - (2,626) Distribution of equity method investment shares to employees as compensation - - 666 - Gain on equity securities - - (1,142) - Loss on exchange of debt for equity 124 - 124 - Unrealized foreign exchange losses 354 1,019 209 1,143 Bad debts expense/provision - - 24 - Reserve for inventory obsolescence (8) - 8 - Stock-based compensation -- compensation and related benefits 227 688 797 2,962 Severance costs 244 239 371 301 Adjusted EBITDA $ (4,105) $ (1,425) $ (13,974) $ (9,394) ============== ================ ============== ============ For the Three Months Ended For the Nine Months Ended September 30, September 30, ------------------------------ (In thousands, except share data) 2023 2022 2023 2022 ------------------------------ -------------- ---------------- -------------- ------------ Net loss attributable to common stockholders $ (10,384) $ (22,631) $ (34,224) $ (64,850) Adjustments: Non-recurring one-time charges: Loss from discontinued operations, net of tax - 7,121 4,856 22,786 Unrealized (gain)/loss on equity securities (5,791) 5,854 (5,733) 7,110 Realized loss on equity securities 6,692 151 6,692 151 Unrealized gain on note - 153 - 325 Acquisition transaction/financing costs 1,656 2 2,343 254 Professional service fees - - - 8 Impairment of goodwill - - - 2,030 Transaction costs 1,527 - 2,970 - Accretion of series 7 preferred stock - - - 4,555 Accretion of series 8 preferred stock - 6,305 - 13,089 Deemed dividend for the modification Series 8 preferred stock - - - 2,627 Deemed contribution for the modification related to warrants issued in connection with the Series 8 Preferred Stock - - - (1,469) Amortization premium - modification to Series 8 preferred stock - (1,265) - (2,626) Distribution of equity method investment shares to employees as compensation - - 666 - Gain on equity securities - - (1,142) - Loss on exchange of debt for equity 124 - 124 - Unrealized foreign exchange losses 354 1,019 209 1,143 Bad debts expense/provision - - 24 - Reserve for inventory obsolescence (8) - 8 - Stock-based compensation - compensation and related benefits 227 688 797 2,962 Severance costs 244 239 371 301 Amortization of intangibles 221 511 671 1,640 Proforma non-GAAP net loss $ (5,138) $ (1,853) $ (21,368) $ (9,964) ============== ================ ============== ============ Proforma non-GAAP net loss per common share - basic and diluted $ (0.08) $ (0.84) $ (0.60) $ (4.78) ============== ================ ============== ============ Weighted average basic and diluted common shares outstanding 65,840,189 2,216,544 35,845,916 2,086,633 ============== ================ ============== ============